PNV 0.38% $2.64 polynovo limited

Ann: First Patient enrolled - SynPath Diabetic Foot Ulcer Trial, page-26

  1. 17,007 Posts.
    lightbulb Created with Sketch. 2410
    Well I can't see the trial details, but yes we should see the result within 12 months and I would predict a positive outcome and eventual reimbursement for this treatment. No doubt they won't all be as impressive as this one, but the nature of BTM healing suggests to me that it might be a more durable outcome than other treatments since it may improve the vascularity of the local tissue.

    https://polynovo.com/wp-content/uploads/2022/06/MKU-017-Case-Report-Infected-Diabetic-Foot-Ulcer.pdf
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.